🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Sandoz Pharmaceuticals d.d. — Licensed Medicines

29 medicines held by Sandoz Pharmaceuticals d.d. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 29 products held by Sandoz Pharmaceuticals d.d.
MedicineActive substanceLicence holderStatus
Aclasta 5 mg solution for infusion
EU/1/05/308/001
Zoledronic acid Sandoz Pharmaceuticals d.d.
ATRIANCE 5mg/ml Solution for Infusion
EU/1/07/403/001
Nelarabine Sandoz Pharmaceuticals d.d.
Estradot 100 micrograms/24 hours, transdermal patch
PA23311/004/004
Estradiol Sandoz Pharmaceuticals d.d. Marketed
Estradot 25 micrograms/24 hours, transdermal patch
PA23311/004/005
Estradiol Sandoz Pharmaceuticals d.d. Not marketed
Estradot 37.5 micrograms/24 hours, transdermal patch
PA23311/004/001
Estradiol Sandoz Pharmaceuticals d.d. Marketed
Estradot 50 micrograms/24 hours, transdermal patch
PA23311/004/002
Estradiol Sandoz Pharmaceuticals d.d. Marketed
Estradot 75 micrograms/24 hours, transdermal patch
PA23311/004/003
Estradiol Sandoz Pharmaceuticals d.d. Marketed
Fortum 1 g powder for solution for injection or infusion
PA23311/001/002
Ceftazidime Sandoz Pharmaceuticals d.d. Marketed
Fortum 2 g powder for solution for injection or infusion
PA23311/001/003
Ceftazidime Sandoz Pharmaceuticals d.d. Marketed
Fortum 500 mg powder for solution for injection
PA23311/001/001
Ceftazidime Sandoz Pharmaceuticals d.d. Marketed
HYCAMTIN 0.25 mg hard capsules
EU/1/96/027/006
Topotecan hydrochloride Sandoz Pharmaceuticals d.d.
HYCAMTIN 1 mg hard capsules
EU/1/96/027/007
Topotecan hydrochloride Sandoz Pharmaceuticals d.d.
Hycamtin 1 mg powder for concentrate for solution for infusion
EU/1/96/027/004
Topotecan (as hydrochloride) Sandoz Pharmaceuticals d.d.
HYCAMTIN 1 mg powder for concentrate for solution for infusion
EU/1/96/027/005
Topotecan (as hydrochloride) Sandoz Pharmaceuticals d.d. Marketed
Hycamtin 4 mg powder for concentrate for solution for infusion
EU/1/96/027/003
Topotecan hydrochloride Sandoz Pharmaceuticals d.d.
HYCAMTIN 4 mg powder for concentrate for solution for infusion
EU/1/96/027/001
Topotecan hydrochloride Sandoz Pharmaceuticals d.d.
Mycamine 100 mg powder for solution for infusion
EU/1/08/448/002
Micafungin sodium Sandoz Pharmaceuticals d.d.
Mycamine 50 mg powder for concentrate for solution for infusion
EU/1/08/448/001
Micafungin sodium Sandoz Pharmaceuticals d.d.
Transiderm-Nitro 10milligram/24 hours Transdermal Patch
PA23311/005/002
Glyceryl trinitrate Sandoz Pharmaceuticals d.d. Marketed
Transiderm-Nitro 15milligrams/24 hours Transdermal Patch
PA23311/005/003
Glyceryl trinitrate Sandoz Pharmaceuticals d.d. Marketed
Transiderm-Nitro 5milligrams/24 hours Transdermal Patch
PA23311/005/001
Glyceryl trinitrate Sandoz Pharmaceuticals d.d. Marketed
Zinacef 1.5 g powder for solution for injection or infusion
PA23311/002/003
Cefuroxime Sodium Sandoz Pharmaceuticals d.d. Marketed
Zinacef 250 mg powder for solution for injection or infusion
PA23311/002/001
Cefuroxime Sodium Sandoz Pharmaceuticals d.d. Marketed
Zinacef 750 mg powder for solution for injection or infusion
PA23311/002/002
Cefuroxime Sodium Sandoz Pharmaceuticals d.d. Marketed
Zinnat 125 mg film-coated tablets
PA23311/003/002
Cefuroxime Sandoz Pharmaceuticals d.d. Marketed
Zinnat 125 mg/5 ml granules for oral suspension
PA23311/003/005
Cefuroxime axetil Sandoz Pharmaceuticals d.d. Marketed
Zinnat 250 mg film-coated tablets
PA23311/003/003
Cefuroxime Sandoz Pharmaceuticals d.d. Marketed
Zinnat 250mg/5ml granules for oral suspension
PA23311/003/001
Cefuroxime axetil Sandoz Pharmaceuticals d.d. Marketed
Zinnat 500 mg film-coated tablets
PA23311/003/004
Cefuroxime Sandoz Pharmaceuticals d.d. Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 19 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.